Viewing Study NCT05161195


Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2025-12-27 @ 9:57 PM
Study NCT ID: NCT05161195
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-21
First Post: 2021-12-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Roll-over Study to Allow Continued Access to Ribociclib
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module